Tenders

Open Framework Agreement on Drug Discounts in Accordance with § 130A Paragraph 8 Sgb V with the Option to Join at any Time, So-Called Approval Model 2023-04

Open House Drug Discount Contracts Ibuprofen, Prescription, in Sustained-Release Dosage Form with a Potency of 800 Mg, Atc M01ae01

Drugs with the Active Substance Combination Tamsulosin and Dutasteride (Atc: G04ca52)

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Cinacalcet (H05bx01) as Part of a So-Called Open House Model.

Drugs with the Active Substance Aripiprazole (Atc: N05ax12 - for Parenteral Administration)

Open House Discount Drug Contracts for Betamethasone and Fusidic Acid, Atc D07cc01

Medicines Containing the Active Substance Zolmitriptan (Atc: N02cc03)

Medicines Containing the Active Ingredient Fulvestrant (Atc: L02ba03)

Open House Drug Discount Contracts Ibuprofen, Prescription, in Immediate-Release Dosage Form with the Potency 400Mg and 600Mg, Atc M01ae01

Open House Drug Discount Agreements Cinacalcet, Atc H05bx01